A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
- PMID:7652577
- DOI: 10.1126/science.7652577
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
Abstract
A mutated cyclin-dependent kinase 4 (CDK4) was identified as a tumor-specific antigen recognized by HLA-A2. 1-restricted autologous cytolytic T lymphocytes (CTLs) in a human melanoma. The mutated CDK4 allele was present in autologous cultured melanoma cells and metastasis tissue, but not in the patient's lymphocytes. The mutation, an arginine-to-cysteine exchange at residue 24, was part of the CDK4 peptide recognized by CTLs and prevented binding of the CDK4 inhibitor p16INK4a, but not of p21 or of p27KIP1. The same mutation was found in one additional melanoma among 28 melanomas analyzed. These results suggest that mutation of CDK4 can create a tumor-specific antigen and can disrupt the cell-cycle regulation exerted by the tumor suppressor p16INK4a.
Similar articles
- Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.Phelps DE, Xiong Y.Phelps DE, et al.Cell Growth Differ. 1998 Aug;9(8):595-610.Cell Growth Differ. 1998.PMID:9716177
- TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.Kamesaki H, et al.J Immunol. 1998 Jan 15;160(2):770-7.J Immunol. 1998.PMID:9551912
- Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.Said TK, Medina D.Said TK, et al.Mol Carcinog. 1998 Jun;22(2):128-43.Mol Carcinog. 1998.PMID:9655257
- Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.Sandhu C, et al.Oncogene. 2000 Nov 9;19(47):5314-23. doi: 10.1038/sj.onc.1203908.Oncogene. 2000.PMID:11103932
- The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.Reynisdóttir I, Massagué J.Reynisdóttir I, et al.Genes Dev. 1997 Feb 15;11(4):492-503. doi: 10.1101/gad.11.4.492.Genes Dev. 1997.PMID:9042862
Cited by
- Establishment of immune suppression by cancer cells in the tumor microenvironment.Nishikawa H.Nishikawa H.Proc Jpn Acad Ser B Phys Biol Sci. 2024;100(2):114-122. doi: 10.2183/pjab.100.005.Proc Jpn Acad Ser B Phys Biol Sci. 2024.PMID:38346752Free PMC article.
- Spleen cells from young but not old immunized mice eradicate large established cancers.Schreiber K, Arina A, Engels B, Spiotto MT, Sidney J, Sette A, Karrison TG, Weichselbaum RR, Rowley DA, Schreiber H.Schreiber K, et al.Clin Cancer Res. 2012 May 1;18(9):2526-33. doi: 10.1158/1078-0432.CCR-12-0127. Epub 2012 Mar 13.Clin Cancer Res. 2012.PMID:22415314Free PMC article.
- Folding of matrix metalloproteinase-2 prevents endogenous generation of MHC class-I restricted epitope.Renaud V, Godefroy E, Larrieu P, Fleury F, Jotereau F, Guilloux Y.Renaud V, et al.PLoS One. 2010 Jul 30;5(7):e11894. doi: 10.1371/journal.pone.0011894.PLoS One. 2010.PMID:20689590Free PMC article.
- Invasive melanoma in Cdk4-targeted mice.Sotillo R, García JF, Ortega S, Martin J, Dubus P, Barbacid M, Malumbres M.Sotillo R, et al.Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13312-7. doi: 10.1073/pnas.241338598. Epub 2001 Oct 23.Proc Natl Acad Sci U S A. 2001.PMID:11606789Free PMC article.
- KinMutBase, a database of human disease-causing protein kinase mutations.Stenberg KA, Riikonen PT, Vihinen M.Stenberg KA, et al.Nucleic Acids Res. 2000 Jan 1;28(1):369-71. doi: 10.1093/nar/28.1.369.Nucleic Acids Res. 2000.PMID:10592276Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials